Growpros Cannabis (MZRRF) 0.0500 $MZRRF
PhytoPain Pharma Reports Successful Pre-CTA Consultation With Health Canada for Its Phase I Trial With Cannabis
Marketwire Canada - Tue Jun 28, 7:31AM CDT
OTTAWA, ONTARIO--(Marketwired - Jun 28, 2016) - PhytoPain Pharma Inc. ("PhytoPain Pharma" or "PPP"
, a subsidiary of GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE:GCI), is pleased to announce a successful pre-CTA (Clinical Trial Application) consultation with the Therapeutic Products Directorate ("TPD" of Health Canada regarding its proposed Phase I clinical study of smoked cannabis. PhytoPain Pharma submitted for review by the regulators, a pre-CTA information package to brief TPD on the planned clinical study and the investigational drug and its comparator (placebo). Health Canada provided feedback and guidance on the Phase I trial's study population, placebo material, and neurological and cognitive assessment measures.
GrowPros Announces the Acquisition of Laboratoires Holizen Inc. and a $600,000 Non-Brokered Private Placement
Marketwired - Wed Jun 22, 7:31AM CDT
OTTAWA, ONTARIO--(Marketwired - Jun 22, 2016) - GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE:GCI) is pleased to announce the acquisition of the assets of Laboratoires Holizen Inc. ("Holizen" for $450,000. The acquisition will be funded by the $600,000 private placement (see below). These assets will be part of the Company's new wholly-owned subsidiary Agro-Tek Inc. and will form a new division of GrowPros' that specializes in the distribution of Natural Health Products ("NHP" and cosmetics. The transaction will provide the Company with an established product line and allow GrowPros to rapidly commercialize and distribute new NHPs and cosmetics through Holizen's strong distribution network.
GrowPros Launches AGORACOM Online Marketing and Awareness Program
Marketwire Canada - Mon Jun 20, 3:30PM CDT
OTTAWA, ONTARIO--(Marketwired - Jun 20, 2016) - GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE:GCI) is pleased to announce that it is implementing an online marketing and awareness program through AGORACOM.
GrowPros Announces Creation of PhytoPain Pharma, a New Subsidiary
Marketwire Canada - Thu Jun 02, 7:31AM CDT
OTTAWA, ONTARIO--(Marketwired - Jun 2, 2016) - GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" or "GCI" (CSE:GCI) is pleased to announce the creation of a new subsidiary PhytoPain Pharma Inc. ("PPP". PPP will be owned 80% by GCI and with 20% owned by Dr. Guy Chamberland, M.Sc., Ph.D. and Mr. André Rancourt as co-founders with GCI.
GrowPros Signs Definitive Agreement in Collaboration With Delta 9 Bio-Tech Inc., a Licensed Producer Under Canada's MMPR
Marketwired - Fri Mar 18, 7:31AM CDT
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE: GCI) is pleased to announce the signing of a definitive agreement (the "Agreement" with Delta 9 Bio-Tech Inc. ("Delta 9", a "Licensed Producer" under Canada's Marijuana for Medical Purposes Regulation ("MMPR" on multiple collaborative ventures.
GrowPros Enters Into Joint Venture Agreement with MMPR License Holder Delta Nine Bio Tech
Marketwired - Thu Mar 03, 7:31AM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE: GCI) is pleased to announce that it has entered into a multi-dimensional joint venture agreement with Canadian Marihuana for Medical Purposes Regulations ("MMPR" license holder Delta 9 Bio Tech ("Delta 9" located in Winnipeg, Manitoba.
GrowPros Begins Permitting Process in Anticipation of Spring Construction Date for Its 50,000 Sq. Ft. Cannabis Production Facility
Marketwired - Thu Jan 14, 7:30AM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE: GCI) is pleased to announce that it has begun the permitting process with both the Local municipal and Quebec provincial governments in anticipation of beginning construction of the proposed 50,000 sq. ft. cannabis production facility for which an application under MMPR was submitted to Health Canada in November of 2014. The status of that application remains unchanged from our last update on October 1, 2015.
GrowPros Appoints New Advisory Board Members, Stock Options Grant Clarification, and Provides Corporate Update
Marketwired - Wed Nov 25, 7:31AM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE: GCI) is pleased to announce the appointments of new members on its Advisory Board, clarify the stock options granted, and provide a corporate update.
GrowPros Grants Options
Marketwired - Tue Nov 10, 7:32AM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE: GCI) announces that on November 5, 2015, in accordance with the Company's stock option plan and subject to the approval of the Canadian Securities Exchange, the Board of Directors granted an aggregate of 3,800,000 incentive stock options ("options" to its officers, directors, consultants, and an employee of the Company. Each option, vesting immediately upon grant, entitles the holder thereof to purchase one common share in the capital of the Company at a price of $0.05 per share until November 5, 2017. The options and any common shares issued upon exercise thereof will be subject to a four month resale restriction from the date of grant.
GrowPros Provides Clarification on Sale of Export Hydro LOI
Marketwired - Fri Nov 06, 3:31PM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE: GCI) is providing shareholders with the following clarification of the execution and subsequent sale of the Export Hydro LOI to Cannabis Accelerators LTD. ("CAL" as originally stated in its July 23 press release.
GrowPros Receives First Payment from Cannabis Accelerators and Export Hydro as Per Agreement and Updates Land Purchase Agreement Related to MMPR Application
Marketwired - Thu Oct 01, 7:31AM CDT
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE: GCI) is pleased to provide shareholders with the following corporate update in regard to several of the Company's initiatives.
PhytoPain Pharma Reports Successful Pre-CTA Consultation With Health Canada for Its Phase I Trial With Cannabis
Marketwire Canada - Tue Jun 28, 7:31AM CDT
OTTAWA, ONTARIO--(Marketwired - Jun 28, 2016) - PhytoPain Pharma Inc. ("PhytoPain Pharma" or "PPP"
, a subsidiary of GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" (CSE:GCI), is pleased to announce a successful pre-CTA (Clinical Trial Application) consultation with the Therapeutic Products Directorate ("TPD" of Health Canada regarding its proposed Phase I clinical study of smoked cannabis. PhytoPain Pharma submitted for review by the regulators, a pre-CTA information package to brief TPD on the planned clinical study and the investigational drug and its comparator (placebo). Health Canada provided feedback and guidance on the Phase I trial's study population, placebo material, and neurological and cognitive assessment measures. GrowPros Announces the Acquisition of Laboratoires Holizen Inc. and a $600,000 Non-Brokered Private Placement
Marketwired - Wed Jun 22, 7:31AM CDT
OTTAWA, ONTARIO--(Marketwired - Jun 22, 2016) - GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company"
(CSE:GCI) is pleased to announce the acquisition of the assets of Laboratoires Holizen Inc. ("Holizen" for $450,000. The acquisition will be funded by the $600,000 private placement (see below). These assets will be part of the Company's new wholly-owned subsidiary Agro-Tek Inc. and will form a new division of GrowPros' that specializes in the distribution of Natural Health Products ("NHP" and cosmetics. The transaction will provide the Company with an established product line and allow GrowPros to rapidly commercialize and distribute new NHPs and cosmetics through Holizen's strong distribution network. GrowPros Launches AGORACOM Online Marketing and Awareness Program
Marketwire Canada - Mon Jun 20, 3:30PM CDT
OTTAWA, ONTARIO--(Marketwired - Jun 20, 2016) - GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company"
(CSE:GCI) is pleased to announce that it is implementing an online marketing and awareness program through AGORACOM. GrowPros Announces Creation of PhytoPain Pharma, a New Subsidiary
Marketwire Canada - Thu Jun 02, 7:31AM CDT
OTTAWA, ONTARIO--(Marketwired - Jun 2, 2016) - GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" or "GCI"
(CSE:GCI) is pleased to announce the creation of a new subsidiary PhytoPain Pharma Inc. ("PPP". PPP will be owned 80% by GCI and with 20% owned by Dr. Guy Chamberland, M.Sc., Ph.D. and Mr. André Rancourt as co-founders with GCI. GrowPros Signs Definitive Agreement in Collaboration With Delta 9 Bio-Tech Inc., a Licensed Producer Under Canada's MMPR
Marketwired - Fri Mar 18, 7:31AM CDT
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company"
(CSE: GCI) is pleased to announce the signing of a definitive agreement (the "Agreement" with Delta 9 Bio-Tech Inc. ("Delta 9", a "Licensed Producer" under Canada's Marijuana for Medical Purposes Regulation ("MMPR" on multiple collaborative ventures. GrowPros Enters Into Joint Venture Agreement with MMPR License Holder Delta Nine Bio Tech
Marketwired - Thu Mar 03, 7:31AM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company"
(CSE: GCI) is pleased to announce that it has entered into a multi-dimensional joint venture agreement with Canadian Marihuana for Medical Purposes Regulations ("MMPR" license holder Delta 9 Bio Tech ("Delta 9" located in Winnipeg, Manitoba. GrowPros Begins Permitting Process in Anticipation of Spring Construction Date for Its 50,000 Sq. Ft. Cannabis Production Facility
Marketwired - Thu Jan 14, 7:30AM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company"
(CSE: GCI) is pleased to announce that it has begun the permitting process with both the Local municipal and Quebec provincial governments in anticipation of beginning construction of the proposed 50,000 sq. ft. cannabis production facility for which an application under MMPR was submitted to Health Canada in November of 2014. The status of that application remains unchanged from our last update on October 1, 2015. GrowPros Appoints New Advisory Board Members, Stock Options Grant Clarification, and Provides Corporate Update
Marketwired - Wed Nov 25, 7:31AM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company"
(CSE: GCI) is pleased to announce the appointments of new members on its Advisory Board, clarify the stock options granted, and provide a corporate update. GrowPros Grants Options
Marketwired - Tue Nov 10, 7:32AM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company"
(CSE: GCI) announces that on November 5, 2015, in accordance with the Company's stock option plan and subject to the approval of the Canadian Securities Exchange, the Board of Directors granted an aggregate of 3,800,000 incentive stock options ("options" to its officers, directors, consultants, and an employee of the Company. Each option, vesting immediately upon grant, entitles the holder thereof to purchase one common share in the capital of the Company at a price of $0.05 per share until November 5, 2017. The options and any common shares issued upon exercise thereof will be subject to a four month resale restriction from the date of grant. GrowPros Provides Clarification on Sale of Export Hydro LOI
Marketwired - Fri Nov 06, 3:31PM CST
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company"
(CSE: GCI) is providing shareholders with the following clarification of the execution and subsequent sale of the Export Hydro LOI to Cannabis Accelerators LTD. ("CAL" as originally stated in its July 23 press release. GrowPros Receives First Payment from Cannabis Accelerators and Export Hydro as Per Agreement and Updates Land Purchase Agreement Related to MMPR Application
Marketwired - Thu Oct 01, 7:31AM CDT
GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company"
(CSE: GCI) is pleased to provide shareholders with the following corporate update in regard to several of the Company's initiatives. 
